Literature DB >> 73182

Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors.

J T Nepom, I Hellström, K E Hellström.   

Abstract

Serum from mice with growing tumors can prevent ("block") the destruction of tumor cells by immune lymphocytes, as measured in a microcytotoxicity assay. Factors responsible for this blocking activity were purified by binding to immune adsorbents that had been prepared from antibodies obtained by immunizing BALB/c mice to the homologous tumors. Two transplantable BALB/c sarcoma lines with individually different tumor-specific transplantation antigens were studied in parallel. The original tumor-specific blocking activity was recovered by elution of the immune adsorbents; that is, (i) eluates blocked the reduction of surviving tumor cell targets by immune lymphocytes only if the tumor specificity, and (ii) immune adsorbent columns prepared from tumor-immune sera recognized the purified blocking fractions in a tumor-specific fashion, indicating that a portion of the humoral response in the immune mice was directed against a factor that was individually distinct for each tumor. Absorption of eluates with the homologous tumor cells removed their blocking activity, indicating that the blocking factors have antigen-binding properties. Blocking activity in the purified fractions resided in molecules presumptively identified as glycoproteins by affinity chromatography on concanavalin A-Sepharose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73182      PMCID: PMC431995          DOI: 10.1073/pnas.74.10.4605

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

Review 1.  Properties of primed suppressor T cells and their products.

Authors:  T Tada; M Taniguchi; T Takemori
Journal:  Transplant Rev       Date:  1975

2.  Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.

Authors:  J Tamerius; J Nepom; I Hellström; K E Hellström
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

3.  Specific anti-tumor responses by cultured immune spleen cells. I. In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicity in vitro.

Authors:  K Nelson; S B Pollack; K E Hellström
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

Review 4.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

5.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

6.  The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

Authors:  S R Cooperband; A M Badger; R C Davis; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

7.  Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

8.  Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas.

Authors:  I Hellström; K E Hellström; H O Sjögren
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

Review 9.  On soluble mediators of immunologic regulation.

Authors:  B H Waksman; Y Namba
Journal:  Cell Immunol       Date:  1976-01       Impact factor: 4.868

10.  Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.

Authors:  K Nelson; S B Pollack; K E Hellström
Journal:  Int J Cancer       Date:  1975-10-15       Impact factor: 7.396

View more
  6 in total

Review 1.  Anti-idiotypic antibodies and the induction of specific tumor immunity.

Authors:  G T Nepom; K E Hellström
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Antigen-specific T-cell factors.

Authors:  M J Taussig
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

Review 3.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

Review 4.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599

5.  T-T hybridoma product specifically suppresses tumor immunity.

Authors:  K Nelson; J Cory; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population.

Authors:  K E Hellström; I Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.